Biocompatibility of alendronate-loaded acrylic cement for vertebroplasty

European Cells and Materials

Volumn 20, Issue , 2010, Pages 260-273

  Calvo Fernandez T ^a   Parra, J ^b,c   Fernandez Gutierrez M ^a   Vazquez Lasa B ^a,c   Lopez Bravo A ^b,c   Collia F ^d   de la Cruz, M A Pérez ^d   San Roman J ^a,c  

^a INSTITUTO DE CIENCIA Y TECNOLOGÍA DE POLÍMEROS   (Spain)

^b HOSPITAL PROVINCIAL DE ÁVILA   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Biocompatibility (in vivo); Cytocompatibility (in vitro); Injectables; Vertebroplasty

Indexed keywords

ALENDRONIC ACID; BIOMATERIAL; BONE CEMENT; POLY(METHYL METHACRYLATE);

ANIMAL; ARTICLE; CELL ADHESION; CHEMISTRY; COMPRESSIVE STRENGTH; CYTOLOGY; FEMALE; FEMUR; HUMAN; METABOLISM; OSTEOBLAST; PERCUTANEOUS VERTEBROPLASTY; POLYMERIZATION; RABBIT;

ALENDRONATE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; CELL ADHESION; COMPRESSIVE STRENGTH; FEMALE; FEMUR; HUMANS; OSTEOBLASTS; POLYMERIZATION; POLYMETHYL METHACRYLATE; RABBITS; VERTEBROPLASTY;

EID: 79952115120     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v020a21     Document Type: Article

References (38)

1. Abbaspour A., Takahashi M, Sairyo K, Takata S, Yukata K, Inui A, Yasui N (2009) Optimal increase in bone mass by continuous local infusion of alendronate during distraction osteogenesis in rabbits. Bone 44: 917-923.
2. Altundal H., Gursoy B (2005) The influence of alendronate on bone formation after autogenous free bone grafting in rats. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 99: 285-291.
3. Black D. M, Cummings SR, Karpf DB, Cauley JA, Thompson D. E, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud K. E (1996) Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348: 1535-1541.
4. Boger A., Benneker LM, Krebs J, Boner V, Heini PF, Gisep A. (2009) The effect of pulsed jet lavage in vertebroplasty on injection forces of PMMA bone cement: an animal study. Eur Spine J 18: 1957-1962.
5. Boivin G., Meunier PJ (2002) Effects of bisphosphonates on matrix mineralization. J Musculoskel Neuronal Interac 2: 538-543.
6. Bone H. G, Downs Jr RW, Tucci JR, Harris ST, Weinstein RS, Licata AA, McClung MR, Kimmel DB, Gertz BJ, Hale E, Polvino WJ (1997) Dose-response relationships for alendronate treatment in osteoporotic elderly women. J Clin Endocrinol Metab 82: 265-274.
7. Bukowski J. F, Dascher CC, Das H (2005) Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 328: 746-750. De la Torre B, Fernandez M, Vazquez B, Collia F, De
8. De la Torre B, Fernandez M, Vazquez B, Collia F, De Pedro J. A, Lopez-Bravo A, San Roman J (2003) Biocompatibility and other properties of acrylic bone cements prepared with antiseptic activators. J Biomed Mater Res B Appl Biomater 66: 502-513.
9. Deb S., Vazquez B, Bonfield W (1997) Effect of crosslinking agents on acrylic bone cements based on poly(methylmethacrylate). J Biomed Mater Res 37: 465-473.
10. Ebisawa Y., Kokubo T, Ohura K, Yamamuro T (1990) Bioactivity of CaO2·SiO2-based glasses: in vitro evaluation. J Mater Sci Mater Med 1: 239-244.
11. Ferracane J. L, Condon JR (1990) Rate of elution of leachable components from composite. Dent Mater 6: 282-287.
12. Healey J. H, Shannon F, Boland P, DiResta GR (2003) PMMA to stabilize bone and deliver antineoplastic and antiresorptive agents. Clin Orthop Relat Res 415 Suppl: S263-S275.
13. Hernandez L., Gurruchaga M, Goñi I (2009) Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. Formulation and rheological behaviour. J Mater Sci Mater Med 20: 89-97.
14. Hughes D. E, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman G. D, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vitro. J Bone Miner Res 10: 1478-1487.
15. Im G. I, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS (2004) Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25: 4105-4115.
16. ISO5833 (2002) Implants for surgery-Acrylic Resins Cements.
17. ISO10993-5 (1999) Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity.
18. ISO10993-6 (1994) Biological evaluation of medical devices. Part 6: Test for local effects after implantation.
19. Itoh F., Aoyagi S, Furihata-Komatsu H, Aoki M, Kusama H., Kojima M, Kogo H (2003) Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures. Eur J Pharmacol 477: 9-16.
20. Kanczler J. M, Oreffo ROC (2008) Osteogenesis and angiogenesis: The potential for engineering bone. Eur Cell Mater 15: 100-114.
21. Legrand C., Bour JM, Jacob C, Capiaumont J, Martial A, Marc A, Wudtke M, Kretzmer G, Demangel C, Duval D, Hache J (1992) Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker. J Biotechnol 25: 231-243.
22. Liberman U. A, Weiss SR, Broll J, Minne HW, Quan H, Bell N. H, Rodriguez-Portales J, Downs Jr RW, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora Ii AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333: 1437-1443.
23. Liu J. T, Liao WJ, Tan WC, Lee JK, Liu CH, Chen YH, Lin T. B (2010) Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporos Int 21: 359-364.
24. Long K. A, Jackson JK, Yang C, Chehroudi B, Brunette DM, Burt HM (2009) Controlled release of alendronate from polymeric films. J Biomater Sci Polym Ed 20:653-672.
25. Mendez J. A, Aguilar MR, Abraham GA, Vazquez B, Dalby M., Di Silvio L, San Romn J (2002) New acrylic bone cements conjugated to vitamin E: curing parameters, properties and biocompatibility. J Biomed Mater Res 62: 299-307.
26. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
27. Nociari M. M, Shalev A, Benias P, Russo C (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods 213: 157-167.
28. Revell P. A, Braden M, Freeman MAR (1998) Review of the biological response to a novel bone cement containing poly(ethyl methacrylate) and N-butyl methacrylate. Biomaterials 19: 1579-1586.
29. Rodriguez-Lorenzo LM, Fernandez M, Parra J, Vazquez B., Lopez-Bravo A, San Roman J (2007) Acrylic injectable and self-curing formulations for the local release of bisphosphonates in bone tissue. J Biomed Mater Res B Appl Biomater 83: 596-608.
30. Sabokbar A., Fujikawa Y, Murray DW, Athanasou NA (1998) Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann Rheum Dis 57: 614-618.
31. Schweikl H., Altmannberger I, Hanser N, Hiller KA, Bolay C., Brockhoff G, Spagnuolo G, Galler K, Schmalz G (2005) The effect of triethylene glycol dimethacrylate on the cell cycle of mammalian cells. Biomaterials 26: 4111-4118.
32. Schweikl H., Spagnuolo G, Schmalz G (2006) Genetic and cellular toxicology of dental resin monomers. J Den Res 85: 870-877.
33. Simpson H. A, N; Yates, AJ; (1996) Bisphosphonate cement composition to prevent aseptic loosening of orthopaedic implant devices. (W.-U. 19960603, ed), USA.
34. Smit R. S, van der Velde D, Hegeman JH (2008) Augmented pin fixation with Cortoss® for an unstable AOA3 type distal radius fracture in a patient with a manifest osteoporosis. Arch Orthop Trauma Surg 128: 989-993.
35. Stadelmann V. A, Gauthier O, Terrier A, Bouler JM, Pioletti D. P (2008) Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A Pilot Study. Eur Cell Mater 16: 10-16.
36. Sun K., Mendel E, Rhines L, Burton A, Liebschner M (2006) Disperse cement filling in vertebroplasty may reduce risk of secondary tissue damage. Eur Cell Mater 11: 12 (abstr).
37. Yoshii E. (1997) Cytotoxic Effects of Acrylates and Methacrylates: Relationships of monomer structures and cytotoxicity. J Biomed Mater Res 37: 517-524.
38. Yu N. YC, Ruys AJ, Zenios M, Godfrey C, McDonald M, Kiely P, Mikulec K, Little DG, Schindeler A (2008) Bisphosphonate-laden acrylic bone cement: mechanical properties, elution performance, and in vivo activity. J Biomed Mater Res B Appl Biomater 87: 482-491.